WASHINGTON – The U.S. Drug Enforcement Administration today announced the release of the 2025 National Drug Threat Assessment (NDTA), DEA’s comprehensive review of the threats posed to the United States by deadly illicit drugs and the violent domestic and international drug trafficking organizations responsible for producing and trafficking the drugs...

WASHINGTON – DEA and nearly 4,500 law enforcement agencies joined forces last month to dispose of more than 620,000 pounds of unneeded and expired medications in an effort to prevent drug misuse and abuse. The spring collection event marked DEA’s 28th National Prescription Drug Take Back Day. Since its inception...

WASHINGTON – The U.S. Drug Enforcement Administration today issued a letter to e-commerce companies regarding the sale of pill presses. As regulated entities under the Controlled Substances Act (CSA), e-commerce platforms are generally required to comply with CSA recordkeeping, identification, and reporting requirements on the distribution, importation, and exportation of...

WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...

WASHINGTON – The U.S. Drug Enforcement Administration has launched a new campaign encouraging the public to make Every Day Take Back Day by utilizing year-round collection sites to dispose of unneeded and unwanted medications. For more than a decade, DEA has worked with state and local law enforcement partners to...

WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available...

DALLAS, TX – A Denton physician has been sentenced to federal prison for drug trafficking violations announced Special Agent in Charge of the DEA Dallas Eduardo A. Chávez today. Stanley Charles Evans, 63, pleaded guilty on Sep. 12, 2022, to conspiracy to distribute and dispense controlled substances and health care...

OKLAHOMA CITY, OK – INTEGRIS ProHealth, Inc., and its parent, INTEGRIS Health, Inc. (collectively, “INTEGRIS”) paid $120,000 to settle civil penalty claims stemming from allegations that Integris Baptist Medical Center Pharmacy (“Integris Pharmacy”), which is owned and operated by INTEGRIS ProHealth, Inc., violated the Comprehensive Drug Abuse Prevention and Control...

DALLAS – The Department of Justice announced today criminal charges against 138 defendants, including 42 doctors, nurses, and other licensed medical professionals, in 31 federal districts across the United States, for their alleged participation in various healthcare fraud schemes that resulted in approximately $1.4 billion in alleged losses. The charges...

DALLAS - An Arlington physician has been convicted of drug crimes, announced today by DEA Dallas Special Agent in Charge Eduardo A. Chávez Following five days of trial, a federal jury convicted physician Clinton Battle, 68, of one count of conspiracy to distribute controlled substances and one count of distribution...